Syntiron
Saint Paul
About Syntiron
Syntiron’s antigen discovery and purification technology targets the bacterial iron transport proteins that are critical for causing an infection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.7M
- Last round: Grant (Jan 2024)
- Website: syntiron.com
- Phone: 651.641.2876
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/syntiron-88439 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.